Your browser doesn't support javascript.
loading
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study.
Qin, Shukui; Ren, Zhenggang; Feng, Yin-Hsun; Yau, Thomas; Wang, Baocheng; Zhao, Haitao; Bai, Yuxian; Gu, Shanzhi; Li, Lindong; Hernandez, Sairy; Xu, Derek-Zhen; Mulla, Sohail; Wang, Yifan; Shao, Hui; Cheng, Ann Lii.
Afiliação
  • Qin S; People's Liberation Army Cancer Center, Jinling Hospital, Nanjing, China.
  • Ren Z; Liver Cancer Institute and Department of Liver Cancer Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Feng YH; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Yau T; Department of Medicine, Haematology, Medical Oncology & Bone Marrow Transplantation Division, Queen Mary Hospital, Hong Kong, China.
  • Wang B; Department of Oncology, General Hospital of Jinan Military Command, Jinan, China.
  • Zhao H; Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, China.
  • Bai Y; Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Gu S; Radioactive Interventional Department, Hunan Cancer Hospital, Changsha, China.
  • Li L; Product Development Oncology, Roche (China) Holding Ltd., Shanghai, China.
  • Hernandez S; Medical Affairs, Genentech, Inc., South San Francisco, California, USA.
  • Xu DZ; Product Development Oncology, Roche (China) Holding Ltd., Shanghai, China.
  • Mulla S; Product Development Biometrics, Hoffmann-La Roche Ltd., Mississauga, Ontario, Canada.
  • Wang Y; Product Development Oncology, Roche (China) Holding Ltd., Shanghai, China.
  • Shao H; Product Development Oncology, Roche (China) Holding Ltd., Shanghai, China.
  • Cheng AL; Department of Medical Oncology, National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan.
Liver Cancer ; 10(4): 296-308, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34414118

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Liver Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Liver Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China